Stripe forms new crypto team to build Web3 payment solutions
Digital payments platform Stripe (STRIP) starts searching for experienced engineers in the crypto space “to build the future…
How India Inc sailed through FY21
An analysis of Nifty 50 firms’ annual reports reveals interesting details about one of the worst years in corporate…
Rental units: $2,225 an ‘affordable’ rent in Montreal, according to Ottawa
MONTREAL – Is a rent of $2,225 per month considered “affordable” in Greater Montreal? Yes, according to the federal…
eBay Vs. Amazon: Which E-Commerce Stock Is The Better Buy?
Is eBay or Amazon the better stock for long-term investors and why does the answer have little to do…
10 Tech Stocks to Buy According to Billionaire James Dinan
In this article, we discuss the 10 best tech stocks to buy according to billionaire James Dinan. You can…
Canada’s Oil Stocks Are Trading At Bargain Basement Prices
This year, the energy sector has emerged as a standout performer in the U.S. stock market, managing to outperform…
8X8, Inc.: Great For Employees, Terrible For Shareholders
8×8 shares are down dramatically since I last wrote about the business. Unfortunately, the shares remain overpriced in my…
SoFi Technologies ( NASDAQ:SOFI ): Investors should keep an eye on Institutional Ownership
Shares of SoFi Technologies, Inc. (NASDAQ:SOFI) have gained as much as 20% in October following a series of analyst…
Ahead of Market: 12 things that will decide stock action on Wednesday
Gaurav Ratnaparkhi, Head of Technical Research, Sharekhan by BNP Paribas said that the Nifty50 has been taking support near…
Here’s Why Inhibrx Stock Is on the Move Today
The first clinical trial results for a candidate for the treatment of alpha-1 antitrypsin deficiency look highly encouraging.
recent post
-
Jan 21 2026 -
Jan 21 2026
-
Jan 21 2026
-
-
Jan 21 2026
